Tag: venous thromboembolism
-
2012 FDA Report On Beyaz Points Out That Younger Women and Girls Are Most At-Risk For Blood Clots
Approved By FDA In 2010, There Has Been No Study Done Yet Regarding Beyaz Safety — Despite Significant Number Of Beyaz Adverse Event Reports (Posted by Tom Lamb at DrugInjuryWatch.com) _____________________________________________________________________ UPDATE: FDA Meeting…
-
Merck’s NuvaRing Increases The Relative Risk For Blood-Clot Side Effects Says Medical Expert After Weighing Competing Studies
And Another Medical Journal Article Concludes Venous Thromboembolism (VTE) Risk Associated With NuvaRing Is As High As YAZ Or Yasmin And Ortho Evra (Posted by Tom Lamb at DrugInjuryWatch.com) In May 2012 I wrote…
-
Merck Funded Study Says There Is No Blood Clot Risk With NuvaRing, While BMJ Medical Journal Article Reports A 90% Increased Risk
Perhaps These Conflicting Findings As Regards Serious NuvaRing Side Effects (PE, DVT, Stroke) Will Prompt FDA To Convene An Advisory Committee Meeting To Consider Safety Of This Vaginal Ring (Posted by Tom Lamb at DrugInjuryWatch.com) Some conflicting and…
-
YAZ / Yasmin: December 2011 FDA Advisory Committees Meeting Background Materials Now Available Online
Expert Reports From YAZ / Yasmin Lawsuits Will Not Be Considered Because Submitted After Deadline Set By FDA (Posted by Tom Lamb at DrugInjuryWatch.com) _____________________________________________________________________ UPDATE: "Bayer Birth Control Pill Benefits Outweigh Risks, Panel…
-
Two More Medical Studies Show Increased Risk Of Blood Clots With Use Of YAZ, Yasmin, And Ocella
Researchers Find Drospirenone (DRSP) Containing Birth Control Pills Increased Risk Of Pulmonary Embolism (PE) And Deep Vein Thrombosis (DVT) (Posted by Tom Lamb at DrugInjuryWatch.com) New research published online in October 2011 by the…
-
YAZ / Yasmin / Ocella: FDA Study Suggests An Increased Risk Of Blood Clots That Can Cause Side Effects Like Pulmonary Embolism
Early Results Suggest An Approximately 1.5-fold Increase In The Risk For Birth Control Pills With Drospirenone (DRSP) (Posted by Tom Lamb at DrugInjuryWatch.com) _____________________________________________________________________ UPDATE: YAZ / Yasmin / Ocella Update: October 2011 FDA…
-
YAZ / Yasmin / Ocella / Beyaz / Safyral: Drug Safety Regulators Focus On Blood Clot Side Effects
EMA Orders New Warning About Risk Of Venous Thromboembolism, While FDA And Health Canada Begin Safety Review (Posted by Tom Lamb at DrugInjuryWatch.com) In recent months there has been a flurry of activity by…
-
Bayer Affirms Safety Of YAZ / Yasmin And Refutes 2011 BMJ Articles About Risk Of Blood Clots
Just As It Did In 2010 Label Change, Bayer Contends New Medical Studies Are Less Reliable Than Other VTE Evidence (Posted by Tom Lamb at DrugInjuryWatch.com) _____________________________________________________________________ UPDATE: New research suggests that women who…
-
Another Rather “Odd” YAZ Label Change By Bayer: March 2011
Provides New Warnings About Certain Side Effects As Regards ALL Birth Control Pills (Not Specific To YAZ) (Posted by Tom Lamb at DrugInjuryWatch.com) The bottom line is this: There is nothing specific about YAZ…